News

The APOE4 gene affects 25% of the population and drives 44% of all Alzheimer's cases, creating a $181 billion annual burden ...
New program combines IV-delivered TRACERTM capsid with bifunctional payload to silence APOE in carriers of the high-risk APOE4 variant while delive ...
Massive proteomics database links gene variant APOE 4 to chronic inflammation.
New study shows APOE ε4 gene drives inflammation tied to Alzheimer’s, Parkinson’s, ALS—offering new paths for early diagnosis ...